International Clinical Trial: SPF of Confira Sunscreen SPF50 Sample-B

Geneva, March 20 -- International Clinical Trials Registry received information related to the study (CTRI/2026/02/104843) titled 'SPF of Confira Sunscreen SPF50 Sample-B' on Feb. 26.

Study Type: PMS

Study Design: Single Arm Study Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Open Label

Primary Sponsor: Confira Laboratories Pvt. Ltd.

Intervention: Intervention1: Test Product: Sunscreen SPF50 Sample-B: Quantity2 mg/sq.cm Route of administration: Topical Frequency: Once Duration: 24 hour Control Intervention1: Reference Sunscreens: Quantity2 mg/sq.cm Route of administration: Topical Frequency: Once Duration: 24 hour

Recruitment Status: Not Recruiti...